222 related articles for article (PubMed ID: 11542750)
1. Late radiation responses in man: current evaluation from results from Hiroshima and Nagasaki.
Schull WJ
Adv Space Res; 1983; 3(8):231-9. PubMed ID: 11542750
[TBL] [Abstract][Full Text] [Related]
2. Neutrons at Hiroshima: how their disappearance affected risk estimates.
Ellett WH
Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
[TBL] [Abstract][Full Text] [Related]
3. The relationship of gamma and neutron radiation to posterior lenticular opacities among atomic bomb survivors in Hiroshima and Nagasaki.
Otake M; Schull WJ
Radiat Res; 1982 Dec; 92(3):574-95. PubMed ID: 7178422
[No Abstract] [Full Text] [Related]
4. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
Otake M; Schull WJ
Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
[TBL] [Abstract][Full Text] [Related]
5. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
Sasaki MS; Endo S; Hoshi M; Nomura T
J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
Ishimaru T; Otake M; Ischimaru M
Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
[No Abstract] [Full Text] [Related]
7. Risk of cancer among atomic bomb survivors.
Shimizu Y; Kato H; Schull WJ
J Radiat Res; 1991 Dec; 32 Suppl 2():54-63. PubMed ID: 1823367
[TBL] [Abstract][Full Text] [Related]
8. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
9. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
[TBL] [Abstract][Full Text] [Related]
10. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M
Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
[TBL] [Abstract][Full Text] [Related]
11. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
Wakabayashi T; Kato H; Ikeda T; Schull WJ
Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
[TBL] [Abstract][Full Text] [Related]
12. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a neutron RBE of 70 (+/- 50) for solid-tumor induction at Hiroshima and Nagasaki and its implications for assessing the effective neutron quality factor.
Zaider M
Health Phys; 1991 Nov; 61(5):631-6. PubMed ID: 1752746
[TBL] [Abstract][Full Text] [Related]
14. Risk coefficients for childhood cancer after intrauterine irradiation: a review.
Wakeford R; Little MP
Int J Radiat Biol; 2003 May; 79(5):293-309. PubMed ID: 12943238
[TBL] [Abstract][Full Text] [Related]
15. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
16. The effects of neutrons in Hiroshima. Implications for the risk estimates.
Kellerer AM
C R Acad Sci III; 1999; 322(2-3):229-37. PubMed ID: 10196677
[TBL] [Abstract][Full Text] [Related]
17. [Review of 30 years study of Hiroshima and Nagasaki atomic bomb survivors. The Japan Radiation Research Society Chiba. Japan, September, 1975].
Gus'kova AK; Sadchikova EN
Med Radiol (Mosk); 1977 Aug; 22(8):69-77. PubMed ID: 927066
[No Abstract] [Full Text] [Related]
18. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
[TBL] [Abstract][Full Text] [Related]
19. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
Otake M; Schull WJ
J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
[TBL] [Abstract][Full Text] [Related]
20. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
Rühm W; Walsh L; Chomentowski M
Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
